33045022|t|Dexmedetomidine use in pediatric strabismus surgery: A systematic review and meta-analysis.
33045022|a|BACKGROUND: Common complications of pediatric strabismus surgery, including emergence agitation (EA), postoperative nausea and vomiting (PONV), and postoperative pain, may be prevented using dexmedetomidine, which is an anxiolytic and analgesic. This systematic review and meta-analysis assessed the effects of dexmedetomidine in patients who had undergone pediatric strabismus surgery. METHOD: Five databases were searched for randomized controlled trials published from database inception to April 2020 that compared dexmedetomidine use with placebo or active comparator use and evaluated EA, PONV, or postoperative pain incidence (main outcomes) in patients who had undergone pediatric strabismus surgery. Oculocardiac reflex (OCR) incidence and postanesthesia care unit (PACU) stay duration were considered as safety outcomes. All meta-analyses were performed using a random-effects model. RESULTS: In the nine studies meeting our inclusion criteria, compared with placebo use, dexmedetomidine use reduced EA incidence [risk ratio (RR): 0.39; 95% confidence interval (CI): 0.25-0.62, I2 = 66%], severe EA incidence (RR: 0.27, 95% CI: 0.17-0.43, I2 = 0%), PONV incidence (RR: 0.33, 95% CI: 0.21-0.54, I2 = 0%), analgesia requirement (RR: 0.38, 95% CI: 0.25-0.57, I2 = 0%), and pain scores (standardized mean difference: -1.02, 95% CI: -1.44 to -0.61, I2 = 75%). Dexmedetomidine also led to lower EA incidence in the sevoflurane group than in the desflurane group (RR: 0.26 for sevoflurane vs. 0.45 for desflurane). Continuous dexmedetomidine infusion (RR: 0.19) led to better EA incidence reduction than did bolus dexmedetomidine infusion at the end of surgery (RR: 0.26) or during the peri-induction period (RR: 0.36). Compared with placebo use, dexmedetomidine use reduced OCR incidence (RR: 0.63; I2 = 40%). No significant between-group differences were noted for PACU stay duration. CONCLUSION: In patients who have undergone pediatric strabismus surgery, dexmedetomidine use may alleviate EA, PONV, and postoperative pain and reduce OCR incidence. Moreover, dexmedetomidine use does not affect the PACU stay duration.
33045022	0	15	Dexmedetomidine	Chemical	MESH:D020927
33045022	33	43	strabismus	Disease	MESH:D013285
33045022	138	148	strabismus	Disease	MESH:D013285
33045022	168	187	emergence agitation	Disease	MESH:D000071257
33045022	194	227	postoperative nausea and vomiting	Disease	MESH:D020250
33045022	229	233	PONV	Disease	MESH:D020250
33045022	240	258	postoperative pain	Disease	MESH:D010149
33045022	283	298	dexmedetomidine	Chemical	MESH:D020927
33045022	403	418	dexmedetomidine	Chemical	MESH:D020927
33045022	422	430	patients	Species	9606
33045022	459	469	strabismus	Disease	MESH:D013285
33045022	611	626	dexmedetomidine	Chemical	MESH:D020927
33045022	687	691	PONV	Disease	MESH:D020250
33045022	696	714	postoperative pain	Disease	MESH:D010149
33045022	744	752	patients	Species	9606
33045022	781	791	strabismus	Disease	MESH:D013285
33045022	801	813	Oculocardiac	Disease	
33045022	1074	1089	dexmedetomidine	Chemical	MESH:D020927
33045022	1251	1255	PONV	Disease	MESH:D020250
33045022	1372	1376	pain	Disease	MESH:D010146
33045022	1457	1472	Dexmedetomidine	Chemical	MESH:D020927
33045022	1511	1522	sevoflurane	Chemical	MESH:D000077149
33045022	1541	1551	desflurane	Chemical	MESH:D000077335
33045022	1572	1583	sevoflurane	Chemical	MESH:D000077149
33045022	1597	1607	desflurane	Chemical	MESH:D000077335
33045022	1621	1636	dexmedetomidine	Chemical	MESH:D020927
33045022	1709	1724	dexmedetomidine	Chemical	MESH:D020927
33045022	1842	1857	dexmedetomidine	Chemical	MESH:D020927
33045022	1997	2005	patients	Species	9606
33045022	2035	2045	strabismus	Disease	MESH:D013285
33045022	2055	2070	dexmedetomidine	Chemical	MESH:D020927
33045022	2093	2097	PONV	Disease	MESH:D020250
33045022	2103	2121	postoperative pain	Disease	MESH:D010149
33045022	2158	2173	dexmedetomidine	Chemical	MESH:D020927
33045022	Negative_Correlation	MESH:D020927	MESH:D013285
33045022	Negative_Correlation	MESH:D020927	MESH:D010149
33045022	Negative_Correlation	MESH:D020927	MESH:D010146
33045022	Negative_Correlation	MESH:D000077149	MESH:D020927
33045022	Negative_Correlation	MESH:D020927	MESH:D000071257
33045022	Negative_Correlation	MESH:D020927	MESH:D020250

